MD Anderson Cancer Center President Ronald DePinho and his executive leadership declined to meet with the investigation committee dispatched by the American Association of University Professors to his institution Thursday.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
